Every 100 ml, it contains:
Synthetic oxytocin 1,000 I.U.
Formulation agents q.s.
Treatment for retained placenta, uterine atony, primary and secondary weaknesses caused by uterine contractions during fetal expulsion, metritis, post-parturition hemorrhage and post-parturition agalactia. Coadjuvant in the treatment of mastitis.
Animal species to which it is intended:
Mares, cows, sows, ewes, female goats, female cats, female dogs and female foxes.
By subcutaneously, intramuscularly or intravenous route.
Mares and cows: 3 to 6 ml intramuscularly or subcutaneously; 2 to 4 ml intravenously. Sows weighing up to 200 kg: 3 ml intramuscularly or subcutaneously; 2 ml intravenously. Sows weighing more than 200 kg: proportional doses. Ewes, goats, female cats, female dogs and female foxes: 0.3 to 1.5 ml intramuscularly or subcutaneously; 0.2 to 1 ml intravenously.
Vials containing 50, 100 or 250 ml. Box containing 12 vials with 10 ml each.